A Comprehensive Analysis of the Comparative Efficacy of Multimodal Diarrhea Therapies in the Paediatric Population
Launched by COMBINED MILITARY HOSPITAL MULTAN · Sep 5, 2024
Trial Information
Current as of September 10, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial aims to find out which combination of treatments works best for children aged 6 months to 5 years who have acute diarrhea. Researchers will compare four different groups of treatments that include supplements like zinc and probiotics, which are good for gut health. The main goal is to see how long it takes for the diarrhea symptoms to go away after starting treatment. This information will help doctors understand the best ways to manage diarrhea in kids and improve care guidelines.
To participate in this study, children must be between 6 months and 5 years old and have acute diarrhea. Parents or caregivers will need to agree to let their child take part in the trial. However, children with chronic diarrhea, severe dehydration, certain allergies, or other serious health issues will not be included. The trial is not recruiting participants yet, but it's an important step toward improving treatment options for childhood diarrhea.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • -
- Inclusion Criteria:
- • Pediatric patients, both male and female, aged 6 months to 5 years presenting with acute diarrhea at CMH Multan.
- • Patients or caregivers willing to provide informed consent for participation in the study.
- Exclusion Criteria:
- • Pediatric Patients with chronic diarrhea or underlying gastrointestinal disorders.
- • Pediatric Patients with severe dehydration requiring immediate medical intervention.
- • Pediatric Patients with a history of allergy or intolerance to any of the study interventions.
- • Pediatric Patients with severe comorbidities or immunocompromised status.
About Combined Military Hospital Multan
The Combined Military Hospital (CMH) Multan is a premier healthcare institution under the Pakistan Army, dedicated to providing high-quality medical care and advancing clinical research. Equipped with state-of-the-art facilities and a multidisciplinary team of experienced healthcare professionals, CMH Multan focuses on improving patient outcomes through innovative treatment protocols and rigorous scientific investigation. As a clinical trial sponsor, CMH Multan is committed to upholding the highest ethical standards and regulatory compliance, fostering collaborations that enhance medical knowledge and contribute to the betterment of public health.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Trial Officials
Muhammad F Shafiq
Study Chair
CMH Multan
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported